Between June 18 and August 3, 2020, Russian scientists enrolled 76 healthy adults aged 18 to 60 in two Phase I/2 trials. In Phase I of each study, one dose of the vaccine was administered intramuscularly with continuous monitoring for 28 days. On day 21, for Phase 2, the volunteers were given a prime-boost vaccination. […]
